Stock Comparison

JNJ vs SDGR

Johnson & Johnson vs Schrodinger Inc

The Verdict

SDGR takes this one.

JNJ

Johnson & Johnson

1.0

out of 10

Distressed

Winner

SDGR

Schrodinger Inc

7.9

out of 10

Solid Pick

Head-to-Head

N/A

Market Cap

$895M

N/A

P/E Ratio

-8.6

N/A

Profit Margin

-68.5%

N/A

Return on Equity

-48.2%

N/A

Debt-to-Equity

0.3

Conservative

Overall Risk

Aggressive

1.0

DVR Score

7.9

The Deep Dive

JNJ1.0/10

Johnson & Johnson (JNJ) remains a fundamentally strong, diversified healthcare conglomerate with an impressive market capitalization. While possessing robust financials, wide economic moats, and consistent performance, its sheer size ($579.46B) fundamentally misaligns with the criteria for 10x growth within a 3-5 year timeframe. A 10x return would necessitate a market cap exceeding $5.7 trillion, ...

Full JNJ Analysis

SDGR7.9/10

Score Change Explanation: The score has been adjusted downwards from 82 to 79 primarily due to two material changes impacting near-term outlook and investor sentiment. Firstly, management announced at the Leerink Conference (March 10, 2026) an *expected revenue decline for 2026*, shifting to an ACV metric, and pushing profitability targets to 2028. This directly impacts financial trajectory and de...

Full SDGR Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.